Overview
Edwards Lifesciences Corporation, based in the United States, operates primarily in the healthcare sector, focusing on the development and marketing of innovative medical solutions for structural heart disease and critical care monitoring. Renowned for its leadership in heart valve therapies, Edwards Lifescategoriesues life-sustaining technologies such as transcatheter aortic valve replacement (TAVR) systems and precision hemodynamic monitoring. The company plays a pivotal role in advancing cardiac and intensive care medicine through its significant investments in R&D and its commitment to clinical education and community engagement programs aimed at improving patient outcomes. Edwards Lifesciences’ dedication to technological innovation continues to set it apart in the medical device industry.
Basic Stats
The share price of Edwards Lifesciences Corporation as of 10 July 2025 is € 66,74 / share. The market cap (or net worth) of Edwards Lifesciences Corporation as of 10 July 2025 is € 39.176,38 MM.
The Factor Analysis chart (below right) shows a view of Edwards Lifesciences Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 39,176.38 MM |
| EV | |
| Shares Out. | 587.00 MM |
| Earnings Date | |
| EPS (TTM) | 7.12 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.08 |
| Beta | 1.17 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.41 |
| ROE | 0.56 |
| ROIC | 0.39 |
| CROIC | 0.18 |
| OCROIC | 0.08 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 97.07 /100 |
| Analyst Sentiment | 29.01 /100 |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Edwards Lifesciences Corporation is € 76,16. The forecasts range from a low of € 61,55 to a high of € 89,76. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Edwards Lifesciences Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-16 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-10 | Citigroup | Buy | Buy | Maintains |
| 2021-12-09 | SVB Leerink | Outperform | Maintains | |
| 2021-12-06 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2021-10-28 | Credit Suisse | Outperform | Maintains | |
| 2021-10-28 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-10-28 | Raymond James | Outperform | Maintains | |
| 2021-08-03 | Goldman Sachs | Neutral | Maintains | |
| 2021-08-02 | Raymond James | Outperform | Maintains | |
| 2021-07-30 | Piper Sandler | Overweight | Maintains | |
| 2021-07-30 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-30 | Deutsche Bank | Hold | Maintains | |
| 2021-07-30 | Canaccord Genuity | Buy | Maintains | |
| 2021-07-30 | Jefferies | Buy | Maintains | |
| 2021-07-30 | Credit Suisse | Outperform | Maintains | |
| 2021-07-30 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-07-30 | SVB Leerink | Outperform | Maintains | |
| 2021-07-27 | Piper Sandler | Overweight | Maintains | |
| 2021-07-20 | SVB Leerink | Outperform | Maintains | |
| 2021-05-25 | Barclays | Overweight | Initiate | |
| 2021-04-21 | Canaccord Genuity | Buy | Maintains | |
| 2021-04-21 | Piper Sandler | Overweight | Maintains | |
| 2021-04-21 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-21 | Raymond James | Outperform | Maintains | |
| 2021-04-15 | Atlantic Equities | Neutral | Initiate | |
| 2021-04-05 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2020-12-16 | Citigroup | Buy | Neutral | Downgrade |
| 2020-12-14 | Morgan Stanley | Overweight | Maintains | |
| 2020-12-11 | Canaccord Genuity | Buy | Maintains | |
| 2024-07-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-05-30 | Goldman Sachs | Buy | Initiate | |
| 2024-05-22 | Citigroup | Neutral | Buy | Upgrade |
| 2024-05-14 | Deutsche Bank | Hold | Buy | Upgrade |
| 2024-05-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-04-26 | Stifel | Hold | Hold | Maintains |
| 2024-04-26 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-04-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-26 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-04-15 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-04-11 | Mizuho | Buy | Buy | Maintains |
| 2024-04-04 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-04-03 | Citigroup | Neutral | Neutral | Maintains |
| 2024-03-26 | OTR Global | Mixed | Positive | Upgrade |
| 2024-03-21 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-03-18 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-03-07 | B of A Securities | Neutral | Buy | Upgrade |
| 2024-02-07 | Stifel | Hold | Hold | Maintains |
| 2024-02-07 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-02-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-07 | Mizuho | Buy | Buy | Maintains |
| 2024-02-02 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2024-01-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-04 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2023-12-22 | Truist Securities | Buy | Buy | Maintains |
| 2023-12-11 | Truist Securities | Buy | Buy | Maintains |
| 2023-12-11 | Citigroup | Buy | Neutral | Downgrade |
| 2023-12-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-28 | Wolfe Research | Peer Perform | Underperform | Downgrade |
| 2023-10-26 | Citigroup | Buy | Buy | Maintains |
| 2023-10-26 | Piper Sandler | Neutral | Neutral | Maintains |
| 2023-10-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-10-26 | Truist Securities | Buy | Buy | Maintains |
| 2023-10-26 | Mizuho | Buy | Buy | Maintains |
| 2023-10-26 | Stifel | Hold | Hold | Maintains |
| 2023-10-26 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-16 | Leerink Partners | Market Perform | Initiate | |
| 2023-10-02 | Citigroup | Buy | Buy | Maintains |
| 2023-09-26 | Oppenheimer | Perform | Outperform | Upgrade |
| 2023-09-08 | Piper Sandler | Neutral | Neutral | Maintains |
| 2023-08-17 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-08-01 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-07-27 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-07-27 | Morgan Stanley | Overweight | Overweight | Reiterate |
| 2023-07-27 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-07-25 | Jefferies | Buy | Buy | Maintains |
| 2023-07-19 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-19 | Baird | Outperform | Initiate | |
| 2023-07-14 | Morgan Stanley | Overweight | Overweight | Reiterate |
| 2023-07-11 | Citigroup | Buy | Buy | Maintains |
| 2023-06-27 | Mizuho | Buy | Buy | Reiterate |
| 2023-05-18 | Truist Securities | Buy | Buy | Maintains |
| 2023-05-04 | RBC Capital | Outperform | Reiterate | |
| 2023-04-28 | Barclays | Overweight | Maintains | |
| 2023-04-27 | Truist Securities | Buy | Maintains | |
| 2023-04-27 | Citigroup | Buy | Maintains | |
| 2023-04-27 | Piper Sandler | Neutral | Maintains | |
| 2023-04-27 | RBC Capital | Outperform | Maintains | |
| 2023-04-27 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-27 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-04-25 | Mizuho | Buy | Maintains | |
| 2023-04-24 | Stifel | Hold | Maintains | |
| 2023-04-17 | Truist Securities | Buy | Maintains | |
| 2023-04-03 | Citigroup | Buy | Maintains | |
| 2023-03-29 | UBS | Neutral | Initiate | |
| 2023-03-08 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2023-02-06 | Raymond James | Outperform | Market Perform | Downgrade |
| 2023-02-01 | Canaccord Genuity | Hold | Maintains | |
| 2023-02-01 | Truist Securities | Buy | Maintains | |
| 2023-01-30 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2023-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-12-13 | Raymond James | Outperform | Maintains | |
| 2022-12-12 | Citigroup | Buy | Maintains | |
| 2022-12-07 | Mizuho | Buy | Maintains | |
| 2022-12-06 | Stifel | Buy | Hold | Downgrade |
| 2022-12-02 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2022-11-28 | RBC Capital | Outperform | Maintains | |
| 2022-11-03 | Goldman Sachs | Neutral | Maintains | |
| 2022-10-31 | Raymond James | Outperform | Maintains | |
| 2022-10-28 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-28 | RBC Capital | Outperform | Maintains | |
| 2022-10-28 | Truist Securities | Buy | Maintains | |
| 2022-10-28 | Citigroup | Buy | Maintains | |
| 2022-10-28 | Wells Fargo | Overweight | Maintains | |
| 2022-10-28 | Piper Sandler | Overweight | Maintains | |
| 2022-10-28 | Oppenheimer | Outperform | Perform | Downgrade |
| 2022-10-26 | Mizuho | Buy | Initiate | |
| 2022-10-18 | Barclays | Overweight | Initiate | |
| 2022-10-14 | Canaccord Genuity | Hold | Maintains | |
| 2022-10-12 | Jefferies | Buy | Initiate | |
| 2022-10-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-09-22 | Truist Securities | Buy | Maintains | |
| 2022-07-29 | Raymond James | Outperform | Maintains | |
| 2022-07-29 | Citigroup | Buy | Maintains | |
| 2022-07-29 | Piper Sandler | Overweight | Maintains | |
| 2022-07-29 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2022-07-20 | Truist Securities | Buy | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Overweight | Maintains | |
| 2022-05-17 | Citigroup | Buy | Maintains | |
| 2022-04-27 | Canaccord Genuity | Buy | Maintains | |
| 2022-04-27 | Raymond James | Outperform | Maintains | |
| 2022-04-27 | RBC Capital | Outperform | Maintains | |
| 2022-04-27 | SVB Leerink | Outperform | Maintains | |
| 2022-04-13 | Truist Securities | Buy | Initiate | |
| 2022-03-16 | Bernstein | Market Perform | Outperform | Upgrade |
| 2022-02-02 | UBS | Neutral | Buy | Upgrade |
| 2022-01-27 | Morgan Stanley | Overweight | Maintains | |
| 2022-01-27 | Raymond James | Outperform | Maintains | |
| 2022-01-27 | SVB Leerink | Outperform | Maintains | |
| 2022-01-21 | SVB Leerink | Outperform | Maintains | |
| 2022-01-07 | Credit Suisse | Outperform | Maintains | |
| 2022-01-07 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-17 | JP Morgan | Neutral | Overweight | Upgrade |
| 2021-12-15 | Citigroup | Neutral | Buy | Upgrade |
| 2021-12-10 | RBC Capital | Outperform | Initiate | |
| 2021-12-10 | Raymond James | Outperform | Maintains | |
| 2021-12-09 | Wells Fargo | Overweight | Maintains | |
| 2021-12-09 | Morgan Stanley | Overweight | Maintains | |
| 2020-12-11 | Raymond James | Outperform | Maintains | |
| 2020-12-11 | SVB Leerink | Outperform | Maintains | |
| 2020-11-18 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-10-22 | Credit Suisse | Outperform | Maintains | |
| 2020-10-22 | Raymond James | Outperform | Maintains | |
| 2020-10-14 | Piper Sandler | Overweight | Maintains | |
| 2020-10-12 | SVB Leerink | Outperform | Maintains | |
| 2020-09-11 | Wolfe Research | Underperform | Initiate | |
| 2020-07-24 | Stifel | Buy | Maintains | |
| 2020-07-24 | Credit Suisse | Outperform | Maintains | |
| 2020-07-24 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-24 | Jefferies | Buy | Maintains | |
| 2020-07-24 | Canaccord Genuity | Buy | Maintains | |
| 2020-07-24 | Piper Sandler | Overweight | Maintains | |
| 2020-07-24 | SVB Leerink | Outperform | Maintains | |
| 2020-07-24 | Raymond James | Outperform | Maintains | |
| 2020-06-29 | Morgan Stanley | Overweight | Maintains | |
| 2020-06-02 | Credit Suisse | Outperform | Maintains | |
| 2020-06-01 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-28 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2020-04-24 | Piper Sandler | Overweight | Maintains | |
| 2020-04-24 | Citigroup | Buy | Maintains | |
| 2020-04-24 | Stifel | Buy | Maintains | |
| 2020-04-24 | CFRA | Buy | Maintains | |
| 2020-04-24 | Raymond James | Outperform | Maintains | |
| 2020-04-24 | Credit Suisse | Outperform | Maintains | |
| 2020-04-24 | Wells Fargo | Overweight | Maintains | |
| 2020-04-24 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-17 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2020-04-06 | Wells Fargo | Overweight | Maintains | |
| 2020-03-27 | Citigroup | Buy | Maintains | |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-13 | CFRA | Sell | Hold | Upgrade |
| 2020-03-06 | Credit Suisse | Outperform | Maintains | |
| 2020-03-05 | Citigroup | Buy | Initiate | |
| 2020-02-13 | Goldman Sachs | Neutral | Initiate | |
| 2020-01-31 | Stifel Nicolaus | Buy | Maintains | |
| 2020-01-31 | Deutsche Bank | Hold | Maintains | |
| 2020-01-31 | UBS | Neutral | Maintains | |
| 2020-01-31 | CFRA | Sell | Maintains | |
| 2020-01-31 | Credit Suisse | Outperform | Maintains | |
| 2020-01-31 | Wells Fargo | Overweight | Maintains | |
| 2020-01-31 | Piper Sandler | Overweight | Maintains | |
| 2020-01-02 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2019-12-09 | PiperJaffray | Overweight | Maintains | |
| 2019-12-06 | Wells Fargo | Outperform | Maintains | |
| 2019-12-06 | Credit Suisse | Outperform | Maintains | |
| 2019-12-06 | Morgan Stanley | Overweight | Maintains | |
| 2019-12-06 | UBS | Neutral | Maintains | |
| 2019-10-24 | Morgan Stanley | Overweight | Maintains | |
| 2019-10-24 | Bank of America | Buy | Reiterate | |
| 2019-10-24 | Raymond James | Outperform | Maintains | |
| 2019-10-24 | Wells Fargo | Outperform | Maintains | |
| 2019-10-24 | Deutsche Bank | Hold | Maintains | |
| 2019-10-24 | Stifel Nicolaus | Buy | Maintains | |
| 2019-10-16 | UBS | Neutral | Maintains | |
| 2019-10-14 | Raymond James | Outperform | Maintains | |
| 2019-10-14 | Credit Suisse | Outperform | Maintains | |
| 2019-09-23 | Piper Jaffray | Overweight | Initiate | |
| 2019-09-06 | Wells Fargo | Outperform | Maintains | |
| 2019-07-24 | Canaccord Genuity | Buy | Maintains | |
| 2019-07-24 | Morgan Stanley | Overweight | Maintains | |
| 2019-07-24 | Credit Suisse | Outperform | Maintains | |
| 2019-07-24 | Raymond James | Outperform | Maintains | |
| 2019-07-24 | BMO Capital | Outperform | Reiterate | |
| 2019-07-24 | Barclays | Underweight | Maintains | |
| 2019-07-24 | JP Morgan | Neutral | Maintains | |
| 2019-07-16 | Morgan Stanley | Overweight | Maintains | |
| 2019-04-24 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2019-04-24 | Raymond James | Outperform | Outperform | Maintains |
| 2019-04-24 | Deutsche Bank | Hold | Hold | Maintains |
| 2019-04-15 | Credit Suisse | Outperform | Outperform | Maintains |
| 2019-03-18 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-03-18 | Bank of America | Buy | Buy | Reiterate |
| 2019-03-12 | UBS | Neutral | Neutral | Maintains |
| 2019-02-25 | Citigroup | Sell | Sell | Maintains |
| 2019-01-18 | Bank of America | Neutral | Buy | Upgrade |
| 2019-01-03 | Deutsche Bank | Hold | Initiate | |
| 2019-01-02 | Citigroup | Sell | Sell | Maintains |
| 2018-12-18 | Credit Suisse | Outperform | Initiate | |
| 2018-12-07 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-12-06 | Jefferies | Buy | Buy | Maintains |
| 2018-12-06 | Raymond James | Outperform | Outperform | Maintains |
| 2018-11-28 | UBS | Neutral | Initiate | |
| 2018-10-29 | Citigroup | Sell | Sell | Maintains |
| 2018-10-16 | Barclays | Underweight | Initiate | |
| 2018-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-02 | Guggenheim | Buy | Neutral | Downgrade |
| 2018-07-31 | Citigroup | Sell | Sell | Maintains |
| 2018-07-27 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-07-27 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-27 | JP Morgan | Neutral | Neutral | Maintains |
| 2018-06-27 | Bernstein | Market Perform | Initiate | |
| 2018-05-31 | Raymond James | Outperform | Initiate | |
| 2018-02-02 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-02-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-02-02 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-04 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2018-01-03 | Evercore ISI Group | Outperform | Initiate | |
| 2018-01-02 | JP Morgan | Overweight | Neutral | Downgrade |
| 2017-10-26 | Deutsche Bank | Hold | Maintains | |
| 2017-10-26 | Morgan Stanley | Overweight | Maintains | |
| 2017-10-25 | Barclays | Equal-Weight | Maintains | |
| 2017-07-27 | Barclays | Equal-Weight | Maintains | |
| 2017-07-10 | Morgan Stanley | Overweight | Maintains | |
| 2017-05-16 | Goldman Sachs | Buy | Initiate | |
| 2017-02-02 | BTIG Research | Buy | Neutral | Downgrade |
| 2017-01-03 | Guggenheim | Neutral | Buy | Upgrade |
| 2016-12-07 | Cowen & Co. | Outperform | Outperform | Maintains |
| 2016-11-08 | Northland Securities | Market Perform | Outperform | Upgrade |
| 2016-07-28 | JMP Securities | Market Outperform | Maintains | |
| 2016-07-27 | Morgan Stanley | Overweight | Maintains | |
| 2016-07-27 | Citigroup | Sell | Maintains | |
| 2016-07-27 | Bank of America | Neutral | Buy | Upgrade |
| 2016-07-27 | BTIG Research | Buy | Maintains | |
| 2016-07-27 | UBS | Buy | Maintains | |
| 2016-07-27 | Barclays | Equal-Weight | Maintains | |
| 2016-06-09 | Guggenheim | Neutral | Initiate | |
| 2016-04-27 | Cowen & Co. | Outperform | Maintains | |
| 2016-04-27 | Citigroup | Sell | Maintains | |
| 2016-04-11 | JP Morgan | Overweight | Maintains | |
| 2016-04-07 | Barclays | Equal-Weight | Maintains | |
| 2016-04-05 | Northland Securities | Outperform | Market Perform | Downgrade |
| 2016-04-04 | Leerink Swann | Outperform | Maintains | |
| 2016-04-04 | BTIG Research | Neutral | Buy | Upgrade |
| 2016-04-04 | BMO Capital | Outperform | Maintains | |
| 2016-04-04 | Jefferies | Buy | Maintains | |
| 2016-04-04 | JP Morgan | Overweight | Maintains | |
| 2016-03-17 | Nomura | Buy | Initiate | |
| 2016-03-07 | SunTrust Robinson Humphrey | Neutral | Maintains | |
| 2016-01-21 | SunTrust Robinson Humphrey | Neutral | Buy | Upgrade |
| 2016-01-05 | Evercore ISI Group | Hold | Initiate | |
| 2015-12-23 | Credit Suisse | Outperform | Maintains | |
| 2015-12-10 | Barclays | Equal-Weight | Maintains | |
| 2015-12-10 | Stifel Nicolaus | Buy | Maintains | |
| 2015-11-12 | Citigroup | Sell | Initiate | |
| 2015-10-09 | Cowen & Co. | Outperform | Initiate | |
| 2015-07-29 | Barclays | Equal-Weight | Maintains | |
| 2015-07-29 | Stifel Nicolaus | Buy | Maintains | |
| 2015-07-13 | Northland Securities | Market Perform | Outperform | Upgrade |
| 2015-07-13 | BMO Capital | Outperform | Maintains | |
| 2015-07-13 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2015-07-06 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-06-09 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2015-05-12 | JP Morgan | Neutral | Overweight | Upgrade |
| 2015-04-24 | Barclays | Equal-Weight | Maintains | |
| 2014-12-10 | Barclays | Equal-Weight | Maintains | |
| 2014-12-09 | JP Morgan | Neutral | Maintains | |
| 2014-12-09 | Barclays | Equal-Weight | Maintains | |
| 2014-12-09 | Bank of America | Neutral | Maintains | |
| 2014-12-09 | Stifel Nicolaus | Buy | Maintains | |
| 2014-12-09 | Deutsche Bank | Hold | Maintains | |
| 2014-12-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2014-12-08 | Credit Suisse | Outperform | Maintains | |
| 2014-12-04 | Bernstein | Outperform | Initiate | |
| 2014-11-07 | Sterne Agee | Buy | Neutral | Downgrade |
| 2014-10-24 | Stifel Nicolaus | Buy | Maintains | |
| 2014-10-24 | Morgan Stanley | Equal-Weight | Maintains | |
| 2014-10-24 | CRT Capital | Buy | Maintains | |
| 2014-09-16 | Canaccord Genuity | Buy | Maintains | |
| 2014-09-11 | Sterne Agee | Buy | Initiate | |
| 2014-08-21 | JMP Securities | Market Outperform | Maintains | |
| 2014-07-30 | Jefferies | Buy | Maintains | |
| 2014-07-30 | Barclays | Equal-Weight | Maintains | |
| 2014-07-30 | Deutsche Bank | Hold | Maintains | |
| 2014-06-11 | JMP Securities | Market Perform | Market Outperform | Upgrade |
| 2014-05-22 | CRT Capital | Buy | Maintains | |
| 2014-05-21 | Canaccord Genuity | Buy | Maintains | |
| 2014-04-25 | Canaccord Genuity | Buy | Maintains | |
| 2014-04-25 | Stifel Nicolaus | Buy | Maintains | |
| 2014-04-15 | JP Morgan | Underweight | Neutral | Upgrade |
| 2014-04-14 | CRT Capital | Fair Value | Buy | Upgrade |
| 2014-04-14 | Barclays | Equal-Weight | Maintains | |
| 2014-04-14 | Bank of America | Neutral | Maintains | |
| 2014-03-24 | Bank of America | Neutral | Maintains | |
| 2014-03-10 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2014-02-20 | BTIG Research | Neutral | Initiate | |
| 2013-12-10 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2013-12-03 | Stifel Nicolaus | Buy | Maintains | |
| 2013-10-30 | JP Morgan | Neutral | Underweight | Downgrade |
| 2013-10-30 | Canaccord Genuity | Buy | Maintains | |
| 2013-10-16 | Citigroup | Neutral | Buy | Upgrade |
| 2013-10-03 | Stifel Nicolaus | Buy | Maintains | |
| 2013-07-18 | Northland Securities | Market Perform | Outperform | Upgrade |
| 2013-06-10 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2013-04-24 | BMO Capital | Market Perform | Maintains | |
| 2013-04-24 | Jefferies | Buy | Maintains | |
| 2013-04-24 | Citigroup | Neutral | Maintains | |
| 2013-04-24 | Wunderlich | Hold | Maintains | |
| 2013-04-24 | Stifel Nicolaus | Buy | Maintains | |
| 2013-04-24 | Lazard | Buy | Neutral | Downgrade |
| 2013-04-24 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2013-03-28 | Goldman Sachs | Buy | Maintains | |
| 2013-03-22 | JP Morgan | Neutral | Maintains | |
| 2013-02-05 | Jefferies | Buy | Maintains | |
| 2013-02-05 | Barclays | Equal-Weight | Maintains | |
| 2013-02-04 | Canaccord Genuity | Buy | Maintains | |
| 2013-01-04 | Deutsche Bank | Hold | Maintains | |
| 2012-12-05 | JP Morgan | Neutral | Maintains | |
| 2012-11-20 | Stifel Nicolaus | Buy | Initiate | |
| 2012-10-22 | Credit Suisse | Neutral | Maintains | |
| 2012-10-22 | Wunderlich | Hold | Maintains | |
| 2012-10-22 | Jefferies | Buy | Maintains | |
| 2012-10-22 | Citigroup | Buy | Neutral | Downgrade |
| 2012-10-21 | Goldman Sachs | Buy | Maintains | |
| 2012-10-16 | Citigroup | Buy | Maintains | |
| 2012-10-09 | Barclays | Equal-Weight | Maintains | |
| 2012-10-09 | RBC Capital | Top Pick | Outperform | Downgrade |
| 2012-10-09 | Canaccord Genuity | Buy | Maintains | |
| 2012-10-09 | UBS | Neutral | Maintains | |
| 2012-10-09 | PiperJaffray | Overweight | Maintains | |
| 2012-10-09 | Goldman Sachs | Buy | Maintains | |
| 2012-09-28 | Jefferies | Buy | Maintains | |
| 2012-07-25 | Wunderlich | Hold | Maintains | |
| 2012-07-25 | Jefferies | Buy | Maintains | |
| 2012-07-25 | Bank of America | Neutral | Maintains | |
| 2012-07-25 | JP Morgan | Neutral | Maintains | |
| 2012-07-25 | Deutsche Bank | Hold | Maintains | |
| 2012-07-13 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2012-07-06 | PiperJaffray | Overweight | Maintains | |
| 2012-06-26 | UBS | Neutral | Buy | Upgrade |
| 2012-06-25 | Canaccord Genuity | Buy | Maintains | |
| 2012-06-07 | Canaccord Genuity | Buy | Maintains | |
| 2012-05-02 | Goldman Sachs | Buy | Maintains | |
| 2012-05-01 | Canaccord Genuity | Buy | Maintains | |
| 2012-04-13 | JP Morgan | Neutral | Maintains | |
| 2012-03-08 | Canaccord Genuity | Buy | Maintains | |
| 2024-11-27 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-13 | Barclays | Overweight | Overweight | Maintains |
| 2025-02-13 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-09-10 | UBS | Neutral | Neutral | Maintains |
| 2024-12-16 | B of A Securities | Neutral | Buy | Upgrade |
| 2024-10-01 | Citigroup | Buy | Buy | Maintains |
| 2024-10-01 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-12-02 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-24 | Baird | Neutral | Neutral | Maintains |
| 2025-04-24 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2024-10-11 | Morgan Stanley | Equal-Weight | Reiterate | |
| 2024-10-07 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-07-25 | Baird | Outperform | Neutral | Downgrade |
| 2024-07-25 | Truist Securities | Buy | Hold | Downgrade |
| 2024-07-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-25 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-07-25 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-25 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-07-25 | TD Cowen | Buy | Hold | Downgrade |
| 2024-07-25 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-07-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-07-25 | Stifel | Hold | Hold | Maintains |
| 2024-07-25 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-07-25 | B of A Securities | Buy | Neutral | Downgrade |
| 2024-10-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-25 | JP Morgan | Overweight | Neutral | Downgrade |
| 2025-01-30 | Stifel | Hold | Buy | Upgrade |
| 2025-02-12 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-02-12 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-02-12 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-02-12 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-25 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-10-25 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-10-25 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-10-25 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-25 | Baird | Neutral | Neutral | Maintains |
| 2024-07-26 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-26 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-07-29 | Wolfe Research | Underperform | Peer Perform | Upgrade |
| 2025-01-16 | Wolfe Research | Peer Perform | Underperform | Downgrade |
| 2024-09-18 | Jefferies | Buy | Hold | Downgrade |
| 2024-12-05 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-12-05 | Stifel | Hold | Hold | Maintains |
| 2024-12-05 | Truist Securities | Hold | Hold | Reiterate |
| 2024-12-05 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-12-05 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-09-13 | Truist Securities | Hold | Hold | Maintains |
| 2024-09-12 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-09-09 | Barclays | Overweight | Overweight | Maintains |
| 2024-09-09 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-11 | Truist Securities | Hold | Hold | Maintains |
| 2025-07-16 | Mizuho | Outperform | Outperform | Maintains |
| 2024-12-11 | Citigroup | Buy | Buy | Maintains |
| 2025-04-25 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-05-13 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-07-25 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-07-25 | Truist Securities | Hold | Hold | Maintains |
| 2025-07-25 | Mizuho | Outperform | Outperform | Maintains |
| 2025-07-25 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-05-22 | Citigroup | Buy | Buy | Maintains |
| 2025-07-25 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-25 | Stifel | Buy | Buy | Maintains |
| 2025-07-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-25 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-07-25 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-25 | Deutsche Bank | Buy | Buy | Maintains |
| 2025-07-25 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-07-25 | Baird | Neutral | Neutral | Maintains |
| 2025-08-07 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
